Anhydrosecoisolariciresinol

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物,专注于信号通路和疾病研究领域。
Anhydrosecoisolariciresinol  纯度: ≥99.0%

Anhydrosecoisolariciresinol 主要源于 Wedelia biflora,具有抗癌活性。 Anhydrosecoisolariciresinol 抑制人乳腺癌细胞系 MCF-7 和 MDA-MB-231 的生长。

Anhydrosecoisolariciresinol

Anhydrosecoisolariciresinol Chemical Structure

CAS No. : 29388-33-8

规格 价格 是否有货 数量
1 mg ¥1230 In-stock
5 mg ¥3200 In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

Anhydrosecoisolariciresinol 相关产品

相关化合物库:

  • Covalent Screening Library Plus
  • Natural Product Library Plus
  • Bioactive Compound Library Plus
  • Natural Product Library
  • Anti-Cancer Compound Library
  • Covalent Screening Library
  • Medicine Food Homology Compound Library
  • Phenols Library
  • Anti-Breast Cancer Compound Library
  • Anti-Cancer Natural Product Library
  • Plant-Sourced Natural Product Library
  • Heterocyclic Compound Library

同靶点产品:

同靶点蛋白产品:

生物活性

Anhydrosecoisolariciresinol is from the flower of Wedelia biflora, has anti-tumor activities[1]. Anhydrosecoisolariciresinol decreases the growth of human breast cancer MCF-7 and MDA-MB-231 cell lines[2].

分子量

344.40

Formula

C20H24O5

CAS 号

29388-33-8

性状

固体

颜色

White to off-white

结构分类
  • Phenylpropanoids
  • Lignans
  • Phenols
  • Polyphenols
初始来源
  • 植物
  • 其他科
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

纯度 & 产品资料

纯度: ≥99.0%

Data Sheet (520 KB) SDS (251 KB)

COA (258 KB)

产品使用指南 (1538 KB)

参考文献
  • [1]. Thu NT, et al. Six new phenolic glycosides and a new ceramide from the flowers of Wedelia biflora and their cytotoxicity against some cancer cell lines. Nat Prod Commun. 2013 Mar;8(3):367-72.  [Content Brief]

    [2]. Lehraiki A, et al. Extraction of lignans from flaxseed and evaluation of their biological effects on breast cancer MCF-7 and MDA-MB-231 cell lines. J Med Food. 2010 Aug;13(4):834-41.  [Content Brief]

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务